🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

RecruitingNAAges 30 Years - anyAllOrbis
NCT06968611 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses. The main questions it aims to answer are: 1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments? 2. What is the cost-effectiveness, mea

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with DM within the last 6 months * Over 30 years of age * Currently treated at the Dinajpur Diabetes Hospital * Possess a mobile phone to receive voice messages * Willingness to participate in the study, and ability to give informed consent Exclusion Criteria: * Other significant causes of vision loss * Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
💊

What it tests

  • Education/information of risk
  • Free eye glasses
📍

Where

2 sites
Gausul Azam BNSB Eye Hospital
Dinajpur, Bangladesh
Dinajpur Diabetes & Swasthoseba Hospital
Dinajpur Sadar, Bangladesh
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy